highly significantP < 0.001
The adjusted results showed that the risk of MetS in the Q2 and Q3 groups remained significantly lower than in the Q1 group, with adjusted OR (95% CI) of 0.77 (0.69–0.87) and 0.70 (0.61–0.80), both reaching highly significant levels ( P < 0.001).